Biotechnology
Pharma firms eye personalized therapies as potential profit drivers amid patent expirations
Industry analysts suggest that pharmaceutical companies facing large patent cliffs may shift focus toward customized treatments based on patients' genetics and lifestyles, rather than traditional blockbuster drugs. The…
1 source23 claims checked13d ago
23 unverifiable
Biblical perspectiveUNHOLY / UNRIGHTEOUS
Full analysis